Supporting Advances in Understanding, Preventing, and Treating Obesity
Learn about the causes and considerations when treating obesity, and hear about research, healthcare, and policy are changing the landscape. Read about why weight lost is often regained and how "Growing evidence suggests that obesity is a disorder of the energy homeostasis system, rather than simply arising from the passive accumulation of excess weight" in our latest scientific statement, Obesity Pathogensis.
Explore highlights of current education across the Endocrine Society.
Obesity Management Workshop 2016
Workshop Webcast | 9.75 AMA PRA Category 1 Credits™ and ABIM MOC Part 2 points
Planning Chairs: Richard Atkinson, Jr., MD; Daniel Bessesen, MD; Marc-Andre Cornier, MD; and William T. Donahoo, MD
Expert faculty focus on advanced practice challenges and highlight emerging therapies and strategies for preventing, diagnosing, and managing obesity.
Treatment of Obesity in Diabetes
ENDO Session | No credit available
W. Timothy Garvey, MD
“Diabetes is not an isolated entity.” Learn clinical relationships between obesity and diabetes that influence treatment strategies in the larger spectrum of cardiometabolic disease.
Endocrine Facts & Figures: Obesity
Research Resource | No credit available
Advisory Panel Chair: Robert A. Vigersky, MD
Updated epidemiological data and in-depth discussion on obesity, metabolic syndrome, and associated comorbidities with current citations and expert insights.
Obesity Pathogenesis: An Endocrine Society Scientific Statement Endocrine Reviews | June 26, 2017 Michael W. Schwartz, Randy J. Seeley, Lori M. Zeltser, Adam Drewnowski, Eric Ravussin, Leanne M. Redman, and Rudolph L. Leibel
Obesity is among the most common and costly chronic disorders worldwide. Estimates suggest that in the United States obesity affects one-third of adults, accounts for up to one-third of total mortality…
Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function JCEM | January 17, 2017 Sarah Zaheer, Ian H. de Boer, Matthew Allison, Jenifer M. Brown, Bruce M. Psaty, Cassianne Robinson-Cohen, Erin D. Michos, Joachim H. Ix, Bryan Kestenbaum, David Siscovick, and Anand Vaidya
Obesity is associated with poor bone mineralization and quality. Fibroblast growth factor 23 (FGF23) plays an important role in skeletal physiology…
Pediatric Obesity—Assessment, Treatment, and Prevention JCEM | January 31, 2017 Dennis M. Styne, Silva A. Arslanian, Ellen L. Connor, Ismaa Sadaf Farooqi, M. Hassan Murad, Janet H. Silverstein, and Jack A. Yanovski
Pediatric obesity remains an ongoing serious international health concern affecting about 17% of United States children and adolescents, threatening their adult health…
Pharmacological Management of Obesity JCEM | January 15, 2015 Caroline M. Apovian, Louis J. Aronne, Daniel H. Bessesen, Marie E. McDonnell, M. Hassan Murad, Uberto Pagotto, Donna H. Ryan, and Christopher D. Still
Weight loss is a pathway to health improvement for patients with obesity-associated risk factors and comorbidities. Medications approved for chronic weight management can be useful adjuncts…
Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient JCEM | April 30, 2011 David Heber, Frank L. Greenway, Lee M. Kaplan, Edward Livingston, Javier Salvador, and Christopher Still
Bariatric surgery is not a guarantee of successful weight loss and maintenance. Increasingly, patients regain weight, especially those undergoing restrictive surgeries such as laparoscopic banding…
For additional meetings, visit the Endocrine Society’s Worldwide Endocrinology Calendar at endocrine.org/calendar.
Clinical Endocrinology Update & Endocrine Board Review Dates: September 23–27, 2017 Location: Chicago, Illinois, United States Sponsor: Endocrine Society
Whether you need the latest clinical information or you’re preparing to certify or recertify for the boards, Clinical Endocrinology Update (CEU) and Endocrine Board Review (EBR) have you covered.
ENDO Bridge Dates: October 19–22, 2017 Location: Antalya, Turkey Sponsor: Endocrine Society, the European Society of Endocrinology, and The Society of Endocrinology and Metabolism of Turkey
EndoBridge will provide a comprehensive update in the field of endocrinology for the clinical endocrinologist. The official language of the meeting is English, but simultaneous translation will be available in Russian, Arabic, and Turkish
ENDO 2018 Dates: March 17–20, 2018 Location: Chicago, Illinois, United States Sponsor: Endocrine Society
ENDO is the world’s largest event for presenting and obtaining the latest in endocrine science and medicine with an extensive program covering a broad array of topics, various networking opportunities, poster sessions, updates on new products and technologies at the ENDOExpo, and more.